Phase II study of amsacrine (AMSA) in previously treated patients with advanced transitional cell carcinoma of the urothelium: a National Bladder Cancer Collaborative Group A study.
D000609:Aminoacridines / Q000627:therapeutic use*; D000677:Amsacrine; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D004848:Epithelium; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D009362:Neoplasm Metastasis; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000609:Aminoacridines; D000677:Amsacrine